Friday, 21 Sep 2018

You are here

Outcomes of Systemic Sclerosis Hospitalization

A study of inpatient systemic sclerosis (SSc) hospitalizations using the 2012–13 National Inpatient Sample database finds an inpatient mortality rate of 5%, and that infection was the most common cause of SSc hospitalizations and in-hospital death.

Researchers from Pennsylvania calculated rates of hospitalization, in-hospital mortality, LOS and hospital costs from 9731 SSc hospitalizations; a sample from an estimated 48 655 nationwide SSc hospitalizations.

Hospitalized patients were predominantly older (63.2 years), female (82.2%) and Caucasian (71.5%).

Infection was the most common cause for SSc hospitalizations (17.4%) and for those who died (32.7%).

Hospital mortality was also associated with acute renal failure (aOR = 4.3, 95% CI: 3.3, 5.60 and aspiration (aOR= 3.5, 95% CI: 2.5, 4.9).

While the median length of stay (LOS) was 4 days, this was significantly prolonged by pulmonary fibrosis, and myositis, infection, acute renal failure, acute bowel obstruction and aspiration (aOR > 2.0 with P < 0.0001).

Higher cost of hospitalization  was predicted by acute renal failure, acute bowel obstruction, and aspiration.

SSc patients are at risk for significant morbidity and mortality, especially if hospitalized with infection or other complications of SSc.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

An Association between GCA and IBD ?

A population based analysis from Israel suggests that giant cell arteritis (GCA) patients may be at increased risk for  inflammatory bowel diseases (IBD) mainly target.

This research was based on sporadic reports in the medical literature (http://bit.ly/2pnIPM0)

Breast Implant Study: More Worries or Not?

The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of  Sjögren's syndrome, scleroderma, rheumatoid arthritis, stillbirth, and melanoma.

New Classification of Idiopathic Inflammatory Myopathies

Using an observational cohort analysis of patients in the French myositis network, researchers have proposed a new classification of idiopathic inflammatory myopathies (IIM) with four subgroups: dermatomyositis, inclusion body myositis, immune-mediated necrotizing myopathy, and antisynthetase syndrome.

Rsearchers set out to define a classification system for IIM based on phenotypic, biological, and immunologic criteria. 

Depression Increases Risk of Systemic Lupus Erythematosus

Twenty-year data from the Nurses’ Health Study (NHS) suggests that depression is associated with a 2-fold increased frequency of systemic lupus erythematosus (SLE) - the question is why?

Interferon Blocker Disappoints in SLE

Yet another setback has occurred in the efforts to develop new medications for treating systemic lupus erythematosus (SLE), as anifrolumab failed to meet the primary endpoint in a phase III trial, according to AstraZeneca and MedImmune.